Target intelligence / Profile preview

MicroRNA 376a-1 (miR-376a-1)

Target
miR-376a-1
Molecular classification
microRNA, non-coding RNA, regulatory RNA, Other
01

Overview

MicroRNA 376a-1 (miR-376a-1) is a small, non-coding regulatory RNA of approximately 20–24 nucleotides encoded on human chromosome 14q32.31[1][3]. It acts post-transcriptionally by binding to complementary sequences in the 3′ untranslated regions (UTRs) of target messenger RNAs (mRNAs), resulting in translational repression or mRNA degradation[3]. miR-376a-1 plays major roles in controlling cellular growth, invasion, cell cycle, and apoptosis, particularly in cancer cells. In glioblastoma multiforme, miR-376a functions as a tumor suppressor by directly targeting the transcription factor specificity protein 1 (SP1), thereby inhibiting cell proliferation and invasion[1][2]. In other cancer types, its expression and function may shift, either suppressing or promoting tumorigenic processes depending on the cellular context and target gene complement. As such, miR-376a-1 is of considerable interest as both a biomarker and a potential therapeutic target in oncology[1][2][3].

Other names
hsa-mir-376ahsa-mir-376a-1MIR376A-1MIR376A1MIRN376AMIRN376A-1MIRN376A1mir-376a-1
02

Mechanism of action

Negative regulation (mRNA degradation or translational repression) of target gene expression (specifically targets such as specificity protein 1 (SP1), Krüppel-like factor 15, caspase-8, p85α, histone deacetylase, insulin-like growth factor 1 receptor, others depending on cancer type)[1][2].

03

Biological functions

post-transcriptional gene regulationregulation of mRNA stabilityinhibition of mRNA translationcell proliferationcell invasionapoptosiscell cycle regulationOther
04

Disease associations

Cancer, specifically glioblastoma multiformehepatocellular carcinomaovarian cancerprostate cancergiant cell tumor of boneOther
05

Safety considerations

Potential for complex and context-dependent effects, as miR-376a can act as a tumor suppressor in some cancers (e.g., glioblastoma, prostate, hepatocellular carcinoma) and as an oncogene in others (e.g., ovarian cancer), so targeting may yield unpredictable results depending on disease and tissue context[1][2].
06

Biomarkers

May serve as a prognostic marker in several cancers, including glioblastoma and prostate cancer[1][2].

Beyond the preview

Go deeper on MicroRNA 376a-1 (miR-376a-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 376a-1 (miR-376a-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call